These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24713315)

  • 21. A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes.
    Meyer JM
    CNS Spectr; 2014 Oct; 19(5):432-8. PubMed ID: 24865765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.
    Mossaheb N; Spindelegger C; Asenbaum S; Fischer P; Barnas C
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):502-5. PubMed ID: 20218805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind study.
    Lin CH; Wang FC; Lin SC; Huang YH; Chen CC; Lane HY
    Int Clin Psychopharmacol; 2013 Sep; 28(5):267-74. PubMed ID: 23778382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polypharmacy in schizophrenia.
    Zink M; Englisch S; Meyer-Lindenberg A
    Curr Opin Psychiatry; 2010 Mar; 23(2):103-11. PubMed ID: 20051861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy in the treatment of schizophrenia.
    Wolff-Menzler C; Hasan A; Malchow B; Falkai P; Wobrock T
    Pharmacopsychiatry; 2010 Jun; 43(4):122-9. PubMed ID: 20309809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polypharmacy in the treatment of schizophrenia].
    Messer T; Tiltscher C; Schmauss M
    Fortschr Neurol Psychiatr; 2006 Jul; 74(7):377-91. PubMed ID: 16804806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.
    Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD
    Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical pharmacotherapy for acute schizophrenia patients.
    Hatta K
    Psychiatry Clin Neurosci; 2015 Nov; 69(11):674-85. PubMed ID: 26037685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Gut Microbiome and Treatment-Resistance in Schizophrenia.
    Seeman MV
    Psychiatr Q; 2020 Mar; 91(1):127-136. PubMed ID: 31781943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing patients with "treatment-resistant" schizophrenia.
    Pantelis C; Lambert TJ
    Med J Aust; 2003 May; 178(S9):S62-6. PubMed ID: 12720525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adequate dosing for second-generation antipsychotics in establishing treatment resistance in schizophrenia.
    Lee J; Remington G
    Am J Psychiatry; 2014 Jan; 171(1):118-9. PubMed ID: 24399431
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological treatment strategies in acute schizophrenia.
    Marder SR
    Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():29-34. PubMed ID: 8803657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of Acute-phase Schizophrenia.
    Hatta K; Ito H
    Clin Psychopharmacol Neurosci; 2014 Apr; 12(1):1-7. PubMed ID: 24851115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms.
    McCutcheon R; Beck K; Bloomfield MA; Marques TR; Rogdaki M; Howes OD
    J Psychopharmacol; 2015 Aug; 29(8):892-7. PubMed ID: 25788157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-resistant Schizophrenia: Evidence-based Strategies.
    Englisch S; Zink M
    Mens Sana Monogr; 2012 Jan; 10(1):20-32. PubMed ID: 22654380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of refractory schizophrenia: pharmacotherapy and clinical implications of blood level measurement of neuroleptics.
    Pi EH; Simpson GM
    Int Pharmacopsychiatry; 1981; 16(3):154-61. PubMed ID: 6119299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing Antipsychotic Dose Versus Switching Antipsychotic for Non Response in Schizophrenia.
    Pich J
    Issues Ment Health Nurs; 2020 Apr; 41(4):373-374. PubMed ID: 31935339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.